X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13721) 13721
Book Review (1301) 1301
Publication (714) 714
Conference Proceeding (63) 63
Magazine Article (40) 40
Dissertation (38) 38
Book Chapter (24) 24
Paper (12) 12
Reference (4) 4
Data Set (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9862) 9862
atorvastatin (9328) 9328
humans (8181) 8181
male (5952) 5952
female (4876) 4876
statins (4592) 4592
atorvastatin calcium (4506) 4506
middle aged (4120) 4120
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3336) 3336
aged (3137) 3137
cholesterol (2763) 2763
pyrroles - therapeutic use (2629) 2629
cardiac & cardiovascular systems (2627) 2627
heptanoic acids - therapeutic use (2626) 2626
simvastatin (2605) 2605
pharmacology & pharmacy (2415) 2415
animals (2235) 2235
treatment outcome (2080) 2080
adult (2069) 2069
pyrroles - pharmacology (1691) 1691
heptanoic acids - pharmacology (1686) 1686
atherosclerosis (1644) 1644
risk factors (1613) 1613
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1607) 1607
pravastatin (1561) 1561
abridged index medicus (1551) 1551
cholesterol, ldl - blood (1520) 1520
anticholesteremic agents - therapeutic use (1453) 1453
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1377) 1377
risk (1334) 1334
peripheral vascular disease (1331) 1331
pyrroles - administration & dosage (1331) 1331
heptanoic acids - administration & dosage (1329) 1329
prevention (1303) 1303
lipids (1279) 1279
therapy (1247) 1247
hypercholesterolemia (1215) 1215
medicine, general & internal (1136) 1136
coronary-heart-disease (1133) 1133
hypercholesterolemia - drug therapy (1117) 1117
rats (1115) 1115
inflammation (1107) 1107
rosuvastatin (1091) 1091
statin (1079) 1079
cardiovascular disease (1050) 1050
disease (1033) 1033
dose-response relationship, drug (1029) 1029
analysis (1024) 1024
drug therapy (1020) 1020
antilipemic agents (1016) 1016
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (979) 979
cardiovascular-disease (883) 883
care and treatment (882) 882
c-reactive protein (875) 875
time factors (866) 866
cardiovascular (861) 861
drug therapy, combination (847) 847
mortality (844) 844
myocardial-infarction (840) 840
research (823) 823
cardiovascular diseases (808) 808
double-blind method (805) 805
prospective studies (800) 800
efficacy (788) 788
cholesterol - blood (782) 782
statin therapy (767) 767
mice (758) 758
simvastatin - therapeutic use (740) 740
safety (721) 721
expression (696) 696
coronary heart disease (677) 677
events (673) 673
lipids - blood (664) 664
diabetes (659) 659
oxidative stress (658) 658
anticholesteremic agents - administration & dosage (657) 657
aged, 80 and over (649) 649
follow-up studies (649) 649
metaanalysis (646) 646
cardiology (642) 642
pyrroles - adverse effects (641) 641
heptanoic acids - adverse effects (639) 639
low density lipoproteins (635) 635
triglycerides - blood (635) 635
cardiovascular agents (628) 628
cardiovascular diseases - prevention & control (624) 624
ezetimibe (612) 612
medicine, research & experimental (608) 608
rosuvastatin calcium (607) 607
anticholesteremic agents - pharmacology (593) 593
acute coronary syndromes (587) 587
cholesterol, hdl - blood (582) 582
coa reductase inhibitors (580) 580
hyperlipidemias - drug therapy (568) 568
biochemistry & molecular biology (558) 558
biomarkers - blood (550) 550
hypertension (546) 546
clinical trials (545) 545
health aspects (543) 543
endocrinology & metabolism (542) 542
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12936) 12936
Spanish (169) 169
Russian (166) 166
German (137) 137
Chinese (134) 134
French (87) 87
Japanese (36) 36
Polish (28) 28
Korean (27) 27
Portuguese (24) 24
Persian (23) 23
Hungarian (21) 21
Turkish (20) 20
Italian (14) 14
Croatian (8) 8
Ukrainian (7) 7
Czech (6) 6
Swedish (5) 5
Dutch (4) 4
Norwegian (4) 4
Danish (3) 3
Lithuanian (2) 2
Slovenian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Heart Journal, ISSN 1349-2365, 2019
The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin... 
Atorvastatin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
by Cao, Z and Wang, Y and Xiao, L and Liu, Z and Zheng, Y
Chinese Journal of Bioprocess Engineering, ISSN 1672-3678, 01/2013, Volume 11, Issue 1, pp. 17 - 22
t-butyl 6-cyano-(3/R,5R)-dihydroxyhexanoate, a key chiral building block for atorvastatin, was synthesized through asymmetric reduction of... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 08/2019, Volume 101, pp. 707 - 708
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 4/2015, Volume 41, Issue 4, pp. 594 - 604
Journal Article
10/2011
Drugs account for 1-2% of all cases of pancreatitis. A 58-year-old man was prescribed atorvastatin 10 mg for 6 months for hyperlipidemia. He developed acute... 
pancreatitis | Adverse drug reaction | atorvastatin
Web Resource
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 02/2019, Volume 164, pp. 258 - 267
Statins, HMG-CoA reductase inhibitors, are considered the first line treatment of hyperlipidemia to reduce the risk of atherosclerotic cardiovascular diseases.... 
Obese subjects from GBS | Hyperlipidemic plasma | Simvastatin and metabolite | Rosuvastatin | Atorvastatin and metabolites | LC–MS/MS | MS-MS METHOD | LC-MS/MS | CHEMISTRY, ANALYTICAL | ACID | SIMULTANEOUS QUANTITATION | PHARMACOLOGY & PHARMACY | SIMULTANEOUS QUANTIFICATION | Simvastatin - therapeutic use | Gastric Bypass | Chromatography, High Pressure Liquid - methods | Hyperlipidemias - blood | Rosuvastatin Calcium - therapeutic use | Humans | Middle Aged | Male | Simvastatin - pharmacology | Obesity - blood | Simvastatin - blood | Atherosclerosis - etiology | Adult | Female | Atorvastatin - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Rosuvastatin Calcium - blood | Tandem Mass Spectrometry - methods | Hyperlipidemias - complications | Obesity - surgery | Tandem Mass Spectrometry - instrumentation | Reproducibility of Results | Obesity - complications | Hyperlipidemias - drug therapy | Rosuvastatin Calcium - pharmacology | Atorvastatin - therapeutic use | Postoperative Period | Chromatography, High Pressure Liquid - instrumentation | Atorvastatin - pharmacology | Calibration | Simvastatin - analogs & derivatives | Atorvastatin - analogs & derivatives | Atherosclerosis - prevention & control | Preoperative Period | Obesity | Medical research | Simvastatin | Gastric bypass | Organic acids | Cardiovascular agents | Antilipemic agents | Metabolites | Analysis | Formic acid | Medicine, Experimental | Nitriles | Index Medicus
Journal Article
NEUROLOGY, ISSN 0028-3878, 08/2016, Volume 87, Issue 7, pp. 746 - 746
Journal Article
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2016, Volume 504, Issue 1-2, pp. 70 - 79
Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 11/2017, Volume 143, Issue 3, pp. 359 - 374
We report that ortho‐hydroxy atorvastatin (o‐ ATV ), which increased glutamate uptake, increased pCREB and provided neuroprotection post‐oxygen/glucose... 
ortho‐hydroxy atorvastatin | receptors | ) | cAMP | OGD | ergic neurons | synaptic | CREB | neuroprotection | GABA | NMDA | response element‐binding protein | oxygen and glucose deprivation | GABAergic neurons | oxygen and glucose deprivation (OGD) | cAMP response element-binding protein (CREB) | synaptic NMDA receptors | ortho-hydroxy atorvastatin | CREB PHOSPHORYLATION | NMDA RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOCAL CEREBRAL-ISCHEMIA | DOPAMINERGIC-NEURONS | NEUROSCIENCES | RAT MODEL | IN-VITRO | ACUTE-PHASE | LIPID RAFTS | METHYL-D-ASPARTATE | Cell Hypoxia - drug effects | Embryo, Mammalian | Cells, Cultured | Receptors, N-Methyl-D-Aspartate - metabolism | GABAergic Neurons - drug effects | Rats | Male | Atorvastatin - pharmacology | Cerebral Cortex - cytology | Rats, Sprague-Dawley | Nerve Tissue Proteins - metabolism | CREB-Binding Protein - metabolism | Glucose - deficiency | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Female | Glutamic Acid - pharmacokinetics | Atorvastatin - analogs & derivatives | Cell Death - drug effects | Tritium - pharmacokinetics | Methyl aspartate | Metabolites | Neurons | Glucose | Glutamate | Statins | Dextrose | Protein binding | Glutamic acid | Neuroprotection | Deprivation | Oxygen | Cell survival | Glutamic acid receptors (ionotropic) | Cortex | N-Methyl-D-aspartic acid receptors | Cultures | Pharmacology | Glutamic acid receptors | Glutamate decarboxylase | Cyclic AMP response element-binding protein | Survival | Receptors | γ-Aminobutyric acid | Rodents | Atorvastatin | Survival factor | All terrain vehicles | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2473 - 2481
Summary Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | PREVENTION | RISK | INTOLERANCE | PARTICIPANTS | Hematologic Diseases - chemically induced | Hypolipidemic Agents - adverse effects | Atorvastatin - adverse effects | Double-Blind Method | Nocebo Effect | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Atorvastatin - administration & dosage | Sleep Wake Disorders | Early Termination of Clinical Trials | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Lymphatic Diseases - chemically induced | Hypolipidemic Agents - administration & dosage | Hypertension - complications | Adult | Female | Hypercholesterolemia - prevention & control | Aged | Muscular Diseases - chemically induced | Clinical trials | Medicine, Experimental | Complications and side effects | Medical research | Epidemiology | Statins | Analysis | Cardiac patients | Sexual disorders | Risk factors | Myocardial infarction | Heart | Therapy | Laboratories | Funding | Physicians | Disorders | Impairment | Cognitive ability | Lipids | Cardiovascular disease | Angina | Matching | Connective tissues | Disturbance | Heart diseases | Public health | Hypertension | Medical personnel | Lymphatic system | Fasting | Effectiveness | Kidneys | Health risks | Erectile dysfunction | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Doctors | Side effects | Sleep | Atorvastatin | Infarction | Health risk assessment | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus | Clinical Medicine | management | clinical-trials | intolerance | risk | cardiovascular-disease | Klinisk medicin | General & Internal Medicine | prevention | participants
Journal Article